September 23, 2023
Webinars
EHI

The Government’s Role in the Future of Ethical Digital Health Innovation

Overview
Dr. John Halamka, President of Mayo Clinic Platform, discusses the importance of public/private partnerships inside the healthcare technology ecosystem. He explains how the government can foster, and not stifle, the innovative tools being created to enhance patient care and ensure positive health outcomes through necessary guidelines, guardrails, and the push for transparency of data collection, protection, and clean data-set composition.

Dr. Halamka explains why there is a need to set a standard metrics with which researchers can use to measure the performance of their AI models in healthcare.

Featured Speaker

  • John Halamka, M.D., M.S., President, Mayo Clinic Platform








Related Resources


Webinars


Telehealth for Diabetes Care: A Program and Policy Framework
April 25, 2024
ATA
Discover the transformative power of telehealth for diabetes management, from education and prevention to comprehensive care, as evidenced by the success stories from various programs. This enlightening webinar delves into the significant impact of telehealth on both preventing and managing diabetes, along with the evolving landscape of policies shaping its future.

   View Video
Webinars
Maximizing Provider Capacity and Improving Access with Asynchronous Care
April 5, 2024
ATA's Async Telehealth Special Interest Group
With increasing provider shortages, patient wait times, and physician burnout, maximizing clinical capacity has become more critical than ever. Discover why leading direct-to-consumer health brands and provider organizations are turning to the power of asynchronous care to address these challenges.

   View Video
Webinars


Policy Update: Navigating the DEA's Geographic Red Flag in Remote Prescribing
March 29, 2024
ATA
This policy update dives into the geographic red flag issue specific to the Drug Enforcement Administration’s (DEA) oversight of remote prescribing of controlled substances. We clarify the issue, outline the key players involved, discuss potential DEA rulemaking as well as its potential impact on state policies, and highlight the urgent stakeholder statement urging the DEA to address this issue.

   View Video